Detalles de la búsqueda
1.
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
PLoS Med
; 4(12): e343, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18052604
2.
Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings.
J Clin Virol
; 36(1): 64-7, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16431154
3.
Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire.
J Clin Virol
; 37(3): 199-205, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16973409
4.
Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing.
J Acquir Immune Defic Syndr
; 44(3): 247-53, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17146373
5.
Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.
J Med Virol
; 78(8): 1003-10, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16789014
6.
Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits.
J Acquir Immune Defic Syndr
; 41(5): 557-62, 2006 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16652029
7.
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss.
J Acquir Immune Defic Syndr
; 40(3): 250-6, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16249697
8.
HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.
J Acquir Immune Defic Syndr
; 33(3): 292-9, 2003 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12843739
Resultados
1 -
8
de 8
1
Próxima >
>>